Genetic Heterogeneity in Cervical Cancer
Author Information
Author(s): Cooke S L, Temple J, MacArthur S, Zahra M A, Tan L T, Crawford R A F, Ng C K Y, Jimenez-Linan M, Sala E, Brenton J D
Primary Institution: Cancer Research UK Cambridge Research Institute
Hypothesis
Does intra-tumour genetic heterogeneity affect chemoradiotherapy response in cervical cancer?
Conclusion
Genetic heterogeneity in advanced cervical cancers may predict poor treatment outcomes.
Supporting Evidence
- Three patients had distinct genetic subpopulations before treatment.
- Genetic changes were observed in response to chemoradiotherapy.
- Patients with heterogeneous tumours had shorter survival times.
Takeaway
Cervical cancer can have different types of cells that respond differently to treatment, which can make it harder to treat.
Methodology
The study analyzed biopsies from 10 cervical cancer patients at multiple time points during treatment to assess genetic changes.
Limitations
The study had a small sample size and may not represent all cervical cancer cases.
Participant Demographics
Patients were recruited from a clinical study, with a mix of squamous cell carcinoma and adenocarcinoma types.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website